These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 19054608

  • 1. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
    Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A.
    Eur Urol; 2009 Jun; 55(6):1440-8. PubMed ID: 19054608
    [Abstract] [Full Text] [Related]

  • 2. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ.
    Eur Urol; 2008 Jun; 53(6):1245-53. PubMed ID: 18343564
    [Abstract] [Full Text] [Related]

  • 3. Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.
    Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ.
    Eur Urol; 2008 Jul; 54(1):181-7. PubMed ID: 18191323
    [Abstract] [Full Text] [Related]

  • 4. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT, Chancellor MB, Kuo HC.
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [Abstract] [Full Text] [Related]

  • 5. Editorial comment on: Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
    Gratzke C, Hedlund P.
    Eur Urol; 2009 Jun; 55(6):1448-9. PubMed ID: 19054607
    [No Abstract] [Full Text] [Related]

  • 6. Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.
    Roosen A, Apostolidis A, Elneil S, Khan S, Panicker J, Brandner S, Fowler CJ, Kessler TM.
    J Urol; 2009 Jul; 182(1):190-5. PubMed ID: 19450843
    [Abstract] [Full Text] [Related]

  • 7. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A, Mearini E, Del Zingaro M, Porena M.
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [Abstract] [Full Text] [Related]

  • 8. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
    Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, Nicita G.
    Eur Urol; 2008 May; 53(5):1013-19. PubMed ID: 17950989
    [Abstract] [Full Text] [Related]

  • 9. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Haferkamp A.
    Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
    [No Abstract] [Full Text] [Related]

  • 10. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A, Dowson C, Khan MS, Dasgupta P.
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration.
    Datta SN, Roosen A, Pullen A, Popat R, Rosenbaum TP, Elneil S, Dasgupta P, Fowler CJ, Apostolidis A.
    J Urol; 2010 Dec; 184(6):2578-85. PubMed ID: 21030043
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J.
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [Abstract] [Full Text] [Related]

  • 13. Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms.
    Mukerji G, Yiangou Y, Agarwal SK, Anand P.
    Urology; 2010 Jun; 75(6):1514.e15-20. PubMed ID: 20346490
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R.
    BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928
    [Abstract] [Full Text] [Related]

  • 15. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
    Apostolidis A, Brady CM, Yiangou Y, Davis J, Fowler CJ, Anand P.
    Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.
    Gamé X, Khan S, Panicker JN, Kalsi V, Dalton C, Elneil S, Hamid R, Dasgupta P, Fowler CJ.
    BJU Int; 2011 Jun; 107(11):1786-92. PubMed ID: 21040367
    [Abstract] [Full Text] [Related]

  • 17. In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.
    Kessler TM, Khan S, Panicker JN, Elneil S, Brandner S, Fowler CJ, Roosen A.
    Eur Urol; 2010 May; 57(5):879-83. PubMed ID: 19765885
    [Abstract] [Full Text] [Related]

  • 18. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.
    Popat R, Apostolidis A, Kalsi V, Gonzales G, Fowler CJ, Dasgupta P.
    J Urol; 2005 Sep; 174(3):984-9. PubMed ID: 16094019
    [Abstract] [Full Text] [Related]

  • 19. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J, Kramer G, Jakse G.
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [Abstract] [Full Text] [Related]

  • 20. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.